Cited by 146Anesthesia and Sedative AgentsHemodynamic Monitoring and TherapyVeterinary Pharmacology and Anesthesia

Effect of remimazolam induction on hemodynamics in patients undergoing valve replacement surgery: A randomized, double-blind, controlled trial

Open access
Liu, Tianxiao, Lai, Ting, Chen, Jing, Lu, Yizhi, He, Fang, Chen, Yanhua, Xie, Yubo·2021·Pharmacology Research & Perspectives

Abstract

Background: The stability of hemodynamics during anesthesia induction in patients undergoing valve replacement surgery is particularly important. Remimazolam is a new type of benzodiazepine drug, with supposed advantages of rapid induction, rapid recovery, stable hemodynamics, and mild respiratory inhibition. Aim: To evaluate the effect of remimazolam anesthesia induction on hemodynamics in patients undergoing valve replacement surgery. Methods: This randomized, double‐blind, controlled trial enrolled consecutive patients undergoing mitral valve replacement (MVR)/aortic valve replacement (AVR)/double‐valve replacement (DVR) surgery on cardiopulmonary bypass (CPB). The study was conducted according to the Consolidated Standards of Reporting Trials statement. Participants were randomly assigned to receive either remimazolam or propofol induction of 30 patients each. All patients, data collectors, and data analyzers were blinded to the group allocation. The primary outcomes were the fluctuations in hemodynamic parameters (the difference of maximum or minimum heart rate to baseline, ▲HR, the difference of maximum or minimum mean arterial pressure to baseline, ▲MAP), the occurrence of cardiovascular events (hypotension, severe bradycardia), and the cumulative norepinephrine doses used per patient, averaged per group during induction. The secondary outcomes were hemodynamic parameters (heart rate, HR, mean arterial pressure, MAP, bispectral index, BIS, plasma lactic acid, Lac, and blood glucose, Glu values). Results: A total of 60 patients with heart valve replacement were included in the final analysis, with 30 patients in each group. The ▲MAP was significantly lower in the remimazolam group than in the propofol group during induction ( p < .05). The incidences of hypotension and the cumulative norepinephrine doses used per patient, averaged per group during induction were significantly lower in the remimazolam group than in the propofol group ( p < .05). Conclusion: Remimazolam may be safe and effective for induction and may as an alternative to propofol during anesthesia induction in patients undergoing valve replacement surgery.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/prp2.851

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 23 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

  1. [1]Domenech B, Pomar JL, Prat‐González S, et al. Valvular heart disease epidemics. J Heart Valve Dis. 2016; 25: 1‐ 7. 29505225
  2. [2]Hollenberg SM. Valvular heart disease in adults: etiologies, classification, and diagnosis. FP Essent. 2017; 457: 11‐ 16. 28671804
  3. [9]Eisenried A, Schüttler J, Lerch M, et al. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part II. Pharmacodynamics of electroencephalogram effects. Anesthesiology. 2020; 132: 652‐ 666. 31972657

Cited by

Sorted by citations

Authors
Liu, T., Lai, T., Chen, J., Lu, Y., He, F., Chen, Y., & Xie, Y.
Affiliations
First Affiliated Hospital of GuangXi Medical University (CN)
Corresponding author
  • Chen, Yanhua
  • Xie, Yubo
Venue
Pharmacology Research & Perspectives
Publisher
Wiley
Published
2021-08-13
Volume
9
Issue
5
Pages
e00851-e00851
ISSN
2052-1707 (ISSN-L)
OpenAlex
W3193194912
Cited by
146
References
23
Citations by year
2026: 9 · 2025: 37 · 2024: 37 · 2023: 31 · 2022: 30 · 2021: 2
FWCI
28.69
Type
journal article
Language
en
Open access
Locations
  • Pharmacology Research & Perspectives (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Natural Science Foundation of Guangxi Province (2018GXNSFAA294007)
Topics
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
  • Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
  • Health Sciences › Veterinary › Small Animals › Veterinary Pharmacology and Anesthesia
Keywords
remimazolam, propofol, anesthesia induction, hemodynamic stability, valve replacement, mitral valve replacement, aortic valve replacement, cardiopulmonary bypass, hypotension, bradycardia, norepinephrine requirement, benzodiazepines
MeSH terms
Adult, Aged, Aortic Valve, Benzodiazepines, Bradycardia, Cardiopulmonary Bypass, Double-Blind Method, Female, Heart Rate, Hemodynamics, Humans, Hypotension, Intraoperative Complications, Male, Middle Aged, Mitral Valve, Norepinephrine, Sympathomimetics, Propofol, Anesthetics, Intravenous, Heart Valve Prosthesis Implantation, Arterial Pressure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review